Skip to main content
Caplight Logo









Womed

Womed

Private
MontpellierHealthcare & Life Scienceshttps://www.womedtech.com/

Last Round

VC Round

Jun 30, 2026

Est. Valuation

$37.32M

Total Funding Raised

$10.35M

Company Overview

Womed is a women's health company that develops intrauterine therapies based on a proprietary, biodegradable polymer technology platform for treating uterine pathologies.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

medical deviceintrauterine devicegynecologybiodegradable polymerdrug delivery systemAsherman syndromehysteroscopic surgeryresorbable implantmedtechfemale infertilityuterine adhesionsfibroid treatmentwomen's health techfemtechsurgical barrier

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Womed Comparables

Compare Womed with similar companies based on industry and business-model similarity.

Womed comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Johnson & Johnson
78%
Rejoni, Inc.
74%
ARC Medical Inc.
73%

Womed Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJun 30, 2026
GrantMay 1, 2024

Key People

Founding team and executive leadership

Gonzague Issenmann

Executive Chairman and CEO

Executive Team

Womed Investors

Notable investors and investment history

Womed investors
InvestorRounds
European Innovation Council FundGrant
IRDI Soridec GestionSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 6, 2026

    Monthly visitors increased 73% MoM.

  • Jan 4, 2026

    Monthly visitors grew 49% MoM, from 908 to 1.4K.

Womed Filings

Explore SEC and related filing metadata, where available.

Womed filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Womed's valuation, stock price, and market status.

Is Womed a public or private company?

Womed is a private company.

What is the current stock price of Womed?

Womed is a private company with no public stock price. No recent secondary market data is available.

How much is Womed worth (valuation)?

Womed's valuation is estimated at $37.3M based on funding round data.

Can I buy Womed stock?

Womed shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Womed's last funding round?

Womed's most recent funding round was VC Round on June 30, 2026.

Who are the main investors in Womed?

Key investors in Womed include European Innovation Council Fund, IRDI Soridec Gestion.

Will Womed IPO soon?

No public IPO plans have been announced for Womed.

How can I track Womed secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Womed's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMontpellier
Employee Range16
Year Founded2018
Last FundingJun 30, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?